a synthetic influenza vaccine composed of the first 81 N-terminal amino acids of H1N1 influenza virus NS1 fused via 9 nucleotide linker to the 157 C-terminal amino acids of the hemagglutinin 2 subunit (HA2); immunization conferred significant protective immunity to human volunteers